Latest Articles

Publication Date
'Ovariostasis' as the main preventive and therapeutic strategy for gynecological pathologies in women of reproductive age.

Ovariostasis is a reversible and temporary suspension of the cyclic ovarian activity, characterized by anovulation and hypogonadotropinemia (low serum concentrations of FSH and LH), which can be observed in case …

Published: April 3, 2025, midnight
Testicular Cancer Awareness - Get Me Giddy

Testicular Cancer Awareness Get Me Giddy

Published: April 2, 2025, 3:46 a.m.
Buy Rating Reaffirmed for Acrivon Therapeutics Amid Promising Endometrial Cancer Data and Strong Financial Position - TipRanks

Buy Rating Reaffirmed for Acrivon Therapeutics Amid Promising Endometrial Cancer Data and Strong Financial Position TipRanks

Published: April 1, 2025, 6:54 p.m.
Cervical cancer: Prevention through awareness, screening - Northside Hospital

Cervical cancer: Prevention through awareness, screening Northside Hospital

Published: April 1, 2025, 3:28 p.m.
Excess heme orchestrates progesterone resistance in uterine endometrial cancer through macrophage polarization and the IL-33/PAX8/PGR axis - ScienceDirect.com

Excess heme orchestrates progesterone resistance in uterine endometrial cancer through macrophage polarization and the IL-33/PAX8/PGR axis ScienceDirect.com

Published: April 1, 2025, 2:47 p.m.
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR - Nature

Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR Nature

Published: April 1, 2025, 1:15 p.m.
Health experts push for campaign to curb diabetes, cancer in young adults - standardmedia.co.ke

Health experts push for campaign to curb diabetes, cancer in young adults standardmedia.co.ke

Published: April 1, 2025, 8:07 a.m.
Curcumin-gold nanoshell mediated near-infrared irradiation on human ovarian cancer cell: in vitro study.

Ovarian cancer is considered a predominant female reproductive malignancy and poses a significant threat due to its 80-90% fatality rate. The typical approach involves surgery and chemotherapy, which due to …

Published: April 1, 2025, midnight
Dr Lee on Responses With Nivolumab in Resectable dMMR Endometrial Cancer - OncLive

Dr Lee on Responses With Nivolumab in Resectable dMMR Endometrial Cancer OncLive

Published: March 31, 2025, 10:21 p.m.
CD8+ T Cell Activation in Endometrial Cancer: Prognostic Implications and Potential for - Frontiers

CD8+ T Cell Activation in Endometrial Cancer: Prognostic Implications and Potential for Frontiers

Published: March 31, 2025, 7:23 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!